BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23280748)

  • 1. Probing AGXT2 enzyme activity in mouse tissue by applying stable isotope-labeled asymmetric dimethyl arginine as substrate.
    Martens-Lobenhoffer J; Rodionov RN; Bode-Böger SM
    J Mass Spectrom; 2012 Dec; 47(12):1594-600. PubMed ID: 23280748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantification of α-keto-δ-(N(G),N(G)-dimethylguanidino)valeric acid: a metabolite of asymmetric dimethylarginine.
    Martens-Lobenhoffer J; Rodionov RN; Drust A; Bode-Böger SM
    Anal Biochem; 2011 Dec; 419(2):234-40. PubMed ID: 21945966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in mice.
    Kittel A; Maas R; König J; Mieth M; Weiss N; Jarzebska N; Hohenstein B; Martens-Lobenhoffer J; Bode-Böger SM; Rodionov RN
    Biochem Biophys Res Commun; 2013 Jan; 430(1):84-9. PubMed ID: 23154179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue.
    Maas R; Tan-Andreesen J; Schwedhelm E; Schulze F; Böger RH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):220-8. PubMed ID: 17296339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomy.
    Rodionov RN; Martens-Lobenhoffer J; Brilloff S; Hohenstein B; Jarzebska N; Jabs N; Kittel A; Maas R; Weiss N; Bode-Böger SM
    Nephrol Dial Transplant; 2014 Nov; 29(11):2035-42. PubMed ID: 25002409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional and metabolic regulation of the metabolite dimethylguanidino valeric acid: an early marker of cardiometabolic disease.
    Wali JA; Koay YC; Chami J; Wood C; Corcilius L; Payne RJ; Rodionov RN; Birkenfeld AL; Samocha-Bonet D; Simpson SJ; O'Sullivan JF
    Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E509-E518. PubMed ID: 32663097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of asymmetric and symmetric dimethylarginine, L-monomethylarginine, L-arginine, and L-homoarginine in biological samples using stable isotope dilution liquid chromatography tandem mass spectrometry.
    Davids M; Swieringa E; Palm F; Smith DE; Smulders YM; Scheffer PG; Blom HJ; Teerlink T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():38-47. PubMed ID: 22682940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.
    Rodionov RN; Murry DJ; Vaulman SF; Stevens JW; Lentz SR
    J Biol Chem; 2010 Feb; 285(8):5385-91. PubMed ID: 20018850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans.
    Jarzebska N; Georgi S; Jabs N; Brilloff S; Maas R; Rodionov RN; Zietz C; Montresor S; Hohenstein B; Weiss N
    Atheroscler Suppl; 2019 Dec; 40():106-112. PubMed ID: 31818439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
    Chobanyan K; Thum T; Suchy MT; Zhu B; Mitschke A; Gutzki FM; Beckmann B; Stichtenoth DO; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):32-41. PubMed ID: 17825631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry.
    Martens-Lobenhoffer J; Bode-Böger SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():140-3. PubMed ID: 22884474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma.
    Schwedhelm E; Maas R; Tan-Andresen J; Schulze F; Riederer U; Böger RH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):211-9. PubMed ID: 17194630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of asymmetric Nα-acetyldimethylarginine in humans: a phase II metabolite of asymmetric dimethylarginine.
    Martens-Lobenhoffer J; Rodionov RN; Bode-Böger SM
    Anal Biochem; 2014 May; 452():25-30. PubMed ID: 24560726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications.
    Becker T; Mevius I; de Vries DK; Schaapherder AF; zu Vilsendorf AM; Klempnauer J; Frölich JC; Tsikas D
    Nitric Oxide; 2009 Feb; 20(1):61-7. PubMed ID: 18948222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
    Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Di Gangi IM; Chiandetti L; Gucciardi A; Moret V; Naturale M; Giordano G
    Anal Chim Acta; 2010 Sep; 677(2):140-8. PubMed ID: 20837180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling.
    Rodionov RN; Jarzebska N; Burdin D; Todorov V; Martens-Lobenhoffer J; Hofmann A; Kolouschek A; Cordasic N; Jacobi J; Rubets E; Morawietz H; O'Sullivan JF; Markov AG; Bornstein SR; Hilgers K; Maas R; Pfluecke C; Chen Y; Bode-Böger SM; Hugo CPM; Hohenstein B; Weiss N
    Sci Rep; 2022 Jun; 12(1):9381. PubMed ID: 35672381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.